Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
All Genders
NCT06731257

Virtual Ward-Assisted Very earLy dIschArge of Low-rIsk STEMI patieNTs: the VALIANT-STEMI Trial

Led by The Leeds Teaching Hospitals NHS Trust · Updated on 2024-12-12

600

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Observational studies have suggested that early discharge (24hrs with follow up virtually by telephone) of patients who are low risk and have had successful treatment following ST elevation myocardial infarction is safe. This has not been tested in a randomised controlled trial. In this trial the study team propose to identify low risk patients and randomise them to usual care or early discharge and follow up virtually by telephone. The primary endpoint would be readmission to hospital or all cause death up to 30 day following the event. If the outcome is positive, the study will assist early discharge of patients, reduce length of stay, potentially improve patient well being and have positive financial implications for the health service

CONDITIONS

Official Title

Virtual Ward-Assisted Very earLy dIschArge of Low-rIsk STEMI patieNTs: the VALIANT-STEMI Trial

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Successful revascularisation following STEMI
  • Zwolle score <=3
  • No bystander disease awaiting inpatient intervention at the time of screening or consent
Not Eligible

You will not qualify if you...

  • Haemodynamic instability (Killip class >I)
  • Left ventricular ejection fraction <45%<40%
  • Sustained ventricular or atrial arrhythmias requiring intervention
  • No support at home or social or physical circumstances preventing early discharge
  • Unable to use home monitoring equipment
  • Unwilling to consent or follow instructions
  • Patients visiting from out of catchment area
  • Out-of hospital cardiac arrest
  • Patients repatriated to their local hospital within 24 hours
  • New or worsening renal failure (creatinine >=1.5x baseline)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Leeds Teaching Hospital NHS Trust

Leeds, United Kingdom, LS9 7TF

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here